Innate Immune Cells in Immune Tolerance After Liver Transplantation
- PMID: 30473690
- PMCID: PMC6237933
- DOI: 10.3389/fimmu.2018.02401
Innate Immune Cells in Immune Tolerance After Liver Transplantation
Abstract
Currently, liver transplantation is the most effective treatment for end-stage liver disease. Immunosuppressive agents are required to be taken after the operations, which have significantly reduced rejection rates and improved the short-term (<1 year) survival rates. However, post-transplant complications related to the immunosuppressive therapy have led to the development of new protocols aimed at protecting renal function and preventing de novo cancer and dysmetabolic syndrome. Donor specific immune tolerance, which means the mature immune systems of recipients will not attack the grafts under the conditions without any immunosuppression therapies, is considered the optimal state after liver transplantation. There have been studies that have shown that some patients can reach this immune tolerance state after liver transplantation. The intrahepatic immune system is quite different from that in other solid organs, especially the innate immune system. It contains a variety of liver specific cells, such as liver-derived dendritic cells, Kupffer cells, liver sinusoidal endothelial cells, liver-derived natural killer (NK) cells, natural killer T (NKT) cells, and so on. Depending on their specific structures and functions, these intrahepatic innate immune cells play important roles in the development of intrahepatic immune tolerance. In this article, in order to have a deeper understanding of the tolerogenic functions of liver, we summarized the molecular mechanisms of immune tolerance induced by intrahepatic innate immune cells after liver transplantation.
Keywords: Kupffer cells; LSECs; NK cells; dendritic cells; immune tolerance; innate immune cells; liver transplantation.
Figures
Similar articles
-
Role of NK, NKT cells and macrophages in liver transplantation.World J Gastroenterol. 2016 Jul 21;22(27):6135-44. doi: 10.3748/wjg.v22.i27.6135. World J Gastroenterol. 2016. PMID: 27468206 Free PMC article. Review.
-
Natural Killer Cells and Liver Transplantation: Orchestrators of Rejection or Tolerance?Am J Transplant. 2016 Mar;16(3):751-7. doi: 10.1111/ajt.13565. Epub 2015 Dec 21. Am J Transplant. 2016. PMID: 26690302 Review.
-
Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?Transpl Immunol. 2011 Jul;25(1):27-33. doi: 10.1016/j.trim.2011.05.006. Epub 2011 May 23. Transpl Immunol. 2011. PMID: 21635950 Clinical Trial.
-
Immunity, tolerance and autoimmunity in the liver: A comprehensive review.J Autoimmun. 2016 Jan;66:60-75. doi: 10.1016/j.jaut.2015.08.020. Epub 2015 Sep 7. J Autoimmun. 2016. PMID: 26358406 Review.
-
Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis.Front Immunol. 2020 Oct 22;11:2111. doi: 10.3389/fimmu.2020.02111. eCollection 2020. Front Immunol. 2020. PMID: 33193293 Free PMC article. Review.
Cited by
-
Innate immune cellular therapeutics in transplantation.Front Transplant. 2023;2:1067512. doi: 10.3389/frtra.2023.1067512. Epub 2023 Mar 31. Front Transplant. 2023. PMID: 37994308 Free PMC article.
-
Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development.Front Physiol. 2023 Feb 2;14:1098467. doi: 10.3389/fphys.2023.1098467. eCollection 2023. Front Physiol. 2023. PMID: 36818443 Free PMC article. Review.
-
HO-1/BMMSC perfusion using a normothermic machine perfusion system reduces the acute rejection of DCD liver transplantation by regulating NKT cell co-inhibitory receptors in rats.Stem Cell Res Ther. 2021 Nov 24;12(1):587. doi: 10.1186/s13287-021-02647-5. Stem Cell Res Ther. 2021. PMID: 34819139 Free PMC article.
-
In the Acute Phase of Trypanosoma cruzi Infection, Liver Lymphoid and Myeloid Cells Display an Ambiguous Phenotype Combining Pro- and Anti-Inflammatory Markers.Front Immunol. 2022 May 26;13:868574. doi: 10.3389/fimmu.2022.868574. eCollection 2022. Front Immunol. 2022. PMID: 35720410 Free PMC article.
-
Bone Mesenchymal Stem Cell-Derived Exosome-Enclosed miR-181a Induces CD4+CD25+FOXP3+ Regulatory T Cells via SIRT1/Acetylation-Mediated FOXP3 Stabilization.J Oncol. 2022 May 26;2022:8890434. doi: 10.1155/2022/8890434. eCollection 2022. J Oncol. 2022. PMID: 35664563 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical